Review highlights lack of comprehensive evaluation for atorvastatin anticancer mechanisms and therapeutic potential.
Review finds lack of research on atorvastatin's anticancer potential.
This narrative review discusses the potential anticancer mechanisms and therapeutic potential of atorvastatin. The authors note that a compr…
A review notes that a comprehensive evaluation of atorvastatin's anticancer mechanisms and potential is currently lacking.
Atorvastatin dose and PCI timing predict hypoperfusion in STEMI patients
New Tool Predicts Heart Damage Risk After Emergency Stent Procedure
This cohort study evaluated 434 patients with acute ST-segment elevation myocardial infarction (STEMI) who underwent primary PCI. Independen…
This new tool could help doctors identify high-risk heart attack patients sooner, potentially improving survival and recovery rates.
Intensive medical treatment failed to reduce major adverse cardiovascular events in women with suspected ANOCA/INOCA over 2.5 years.
Intensive heart medication did not reduce major events in women with suspected ANOCA
This randomized controlled trial enrolled 2,476 women with suspected ANOCA/INOCA across 71 US sites. Over a 2.5-year follow-up, intensive me…
Intensive heart medication did not reduce major events in women with suspected ANOCA, finding that aggressive treatment offered no benefit o…
High-dose atorvastatin reduces contrast-induced acute kidney injury after coronary angiography in Egyptian patients
Can a common cholesterol drug protect kidneys during heart imaging?
A randomized controlled trial of 120 Egyptian patients undergoing elective coronary angiography found that adding high-dose atorvastatin (80…
A common cholesterol drug cut kidney injury risk in half compared to fluids alone during heart imaging tests.
Very high-intensity statin with ezetimibe lowers LDL-C more than high-intensity regimen after AMI
Can a stronger statin dose after a heart attack lower cholesterol more?
A single-center RCT of 220 AMI patients compared very high-intensity vs. high-intensity statin, both with ezetimibe, initiated during hospit…
A stronger statin dose after a heart attack lowers bad cholesterol better but causes more side effects, forcing some patients to cut back on…
Atorvastatin evaluated for dyslipidemia in children with steroid-sensitive nephrotic syndrome
Can a common cholesterol drug protect children's hearts and kidneys from a hidden danger?
A quasi-experimental study of 100 children aged 8-18 years with steroid-sensitive nephrotic syndrome and dyslipidemia evaluated the effectiv…
A common cholesterol drug called atorvastatin may help children with kidney disease reach safer heart and blood fat levels when diet alone i…